| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Rovanersen |
ROVANERSEN |
2072901-32-5 |
詳細(xì)
|
| Ibuprofen sodium |
布洛芬鈉 |
31121-93-4 |
詳細(xì)
|
| 7-Epi-10-oxo-docetaxel |
3-[(4-氰基苯基)甲基]-N-(3-甲基-5-異噻唑基)-ALPHA-氧代-1-中氮茚乙酰胺 |
501948-05-6 |
詳細(xì)
|
| Tivozanib hydrochloride hydrate |
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-異惡唑基)脲 |
682745-41-1 |
詳細(xì)
|
| BMS-986176 |
BMS-986176 |
1815613-42-3 |
詳細(xì)
|
| Capmatinib dihydrochloride hydrate |
鹽酸卡瑪替尼一水合物 |
1865733-40-9 |
詳細(xì)
|
| Molnupiravir |
莫那比拉韋 |
2492423-29-5 |
詳細(xì)
|
| Povorcitinib |
INCB54707 |
1637677-22-5 |
詳細(xì)
|
| Manganese(salen) chloride |
N,N'-雙(亞水楊基)-1,2-乙二胺-錳(II) |
53177-12-1 |
詳細(xì)
|
| Aleplasinin |
PAZ 417 |
481629-87-2 |
詳細(xì)
|
| LY900009 |
LY900009 |
209984-68-9 |
詳細(xì)
|
| Ferric citrate |
檸檬酸鐵 |
3522-50-7 |
詳細(xì)
|
| FK614 |
FK-614 |
193012-35-0 |
詳細(xì)
|
| LMP744 |
308246-52-8 |
308246-52-8 |
詳細(xì)
|
| Itacnosertib |
N4-([2,2-bipyridin]-3-yl)-N2-(3-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-2,4-diamine |
1628870-27-8 |
詳細(xì)
|
| BMS-587101 |
BMS587101 |
509083-77-6 |
詳細(xì)
|
| PF-06648671 |
PF-06648671 |
1587727-31-8 |
詳細(xì)
|
| Rineterkib |
ERK-IN-1 (COMPOUND B) |
1715025-32-3 |
詳細(xì)
|
| Gamcemetinib |
化合物 CC-99677 |
1887069-10-4 |
詳細(xì)
|
| Ruboxistaurin |
魯伯斯塔 |
169939-94-0 |
詳細(xì)
|
| S65487 sulfate |
S65487 SULFATE |
2416937-01-2 |
詳細(xì)
|
| Ombrabulin hydrochloride |
達(dá)夫奈肽 |
211439-12-2 |
詳細(xì)
|
| CD73-IN-3 |
5-[6-甲基-5-[(1S,2R)-2-丙-2-基環(huán)丙基]噠嗪-3-基]-1H-嘧啶-2,4-二酮 |
2375815-63-5 |
詳細(xì)
|
| Milvexian |
BMS-986165 |
1802425-99-5 |
詳細(xì)
|
| Pelcitoclax |
APG-1252 |
1619923-36-2 |
詳細(xì)
|
| TAK-020 |
化合物TAK-020 |
1627603-21-7 |
詳細(xì)
|
| Navocaftor |
NAVOCAFTOR |
2159103-66-7 |
詳細(xì)
|
| RP-6306 |
RP-6306 |
2719793-90-3 |
詳細(xì)
|
| THK5351 |
1707147-26-9 |
1707147-26-9 |
詳細(xì)
|
| Streptomycin |
鏈霉素 |
57-92-1 |
詳細(xì)
|
| Simmiparib |
SIMMIPARIB |
1551355-46-4 |
詳細(xì)
|
| BMS-986242 |
Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]- |
1923844-48-7 |
詳細(xì)
|
| Ispronicline |
(2S,4E)-5-(5-異丙基吡啶-3-)-N-甲基戊-4-烯-2-胺 |
252870-53-4 |
詳細(xì)
|
| Ethaselen |
217798-39-5 |
217798-39-5 |
詳細(xì)
|
| AZ7550 Mesylate |
AZ7550 Mesylate |
2319837-99-3 |
詳細(xì)
|
| Telatinib mesylate |
Telatinib mesylate |
332013-26-0 |
詳細(xì)
|
| Bersacapavir |
化合物 T32308 |
1638266-40-6 |
詳細(xì)
|
| Zelquistinel |
AGN-241751; GATE-251 |
2151842-64-5 |
詳細(xì)
|
| RGLS4326 |
RGLS4326 |
2229964-07-0 |
詳細(xì)
|
| ABN401 |
化合物 ABN401 |
2242563-15-9 |
詳細(xì)
|
| Acetic acid magnesium tetrahydrate |
四水醋酸鎂 |
16674-78-5 |
詳細(xì)
|
| Relacatib |
RELACATIB |
362505-84-8 |
詳細(xì)
|
| Troleandomycin |
竹桃霉素三乙酸酯 |
2751-09-9 |
詳細(xì)
|
| Vidarabine monohydrate |
CYCLOPROPAVIR |
632325-71-4 |
詳細(xì)
|
| Asundexian |
ASUNDEXIAN |
2064121-65-7 |
詳細(xì)
|
| Tivanisiran |
TIVANISIRAN |
1848224-71-4 |
詳細(xì)
|
| Tofersen |
TOFERSEN |
2088232-70-4 |
詳細(xì)
|
| Chiglitazar |
CHIGLITAZAR |
743438-45-1 |
詳細(xì)
|
| Izencitinib |
3-((1R,3S,5S)-3-((7-((5-Methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile |
2051918-33-1 |
詳細(xì)
|
| PF 05089771 tosylate |
Flecainide hydrochloride |
57415-44-8 |
詳細(xì)
|
| Ziftomenib |
ZIFTOMENIB |
2134675-36-6 |
詳細(xì)
|
| S65487 |
S-65487 |
1644600-79-2 |
詳細(xì)
|
| Pactimibe sulfate |
帕替麥布 |
608510-47-0 |
詳細(xì)
|
| Sunvozertinib |
DZD 9008 |
2370013-12-8 |
詳細(xì)
|
| Zeteletinib |
ZETELETINIB |
2216753-97-6 |
詳細(xì)
|
| Cabamiquine succinate |
琥珀酸DDD107498 |
2444781-71-7 |
詳細(xì)
|
| TAK-418 |
化合物 TAK-418 |
1818252-53-7 |
詳細(xì)
|
| Luxeptinib |
CG-806 |
1616428-23-9 |
詳細(xì)
|
| Cytidine 5'-diphosphate trisodium salt |
胞苷5-雙磷酸自由酸的3鈉鹽 |
34393-59-4 |
詳細(xì)
|
| Sodium pyrophosphate |
焦磷酸二氫二鈉 |
7758-16-9 |
詳細(xì)
|
| Quabodepistat |
OPC-167832 |
1883747-71-4 |
詳細(xì)
|
| GSK3494245 |
化合物 GSK3494245 |
2080410-41-7 |
詳細(xì)
|
| ACT-451840 |
(E) -N-[[4-(4-乙酰基哌嗪-1-基)苯基]甲基]-3-(4-叔丁基苯基)-N-[(2S)-1-[4-[(4-氰基苯基)甲基]哌嗪-1-基]-1-氧代-3-苯基丙-2-基]丙-2-烯酰胺 |
1984890-99-4 |
詳細(xì)
|
| Zandatrigine |
NBI-921352; XEN901 |
2154406-04-7 |
詳細(xì)
|
| Gunagratinib |
GUNAGRATINIB |
2211082-53-8 |
詳細(xì)
|
| Canrenoate potassium |
坎利酸鉀 |
2181-04-6 |
詳細(xì)
|
| GDC-0310 |
GDC-0310 |
1788063-52-4 |
詳細(xì)
|
| Sonlicromanol hydrochloride |
SONLICROMANOL HYDROCHLORIDE |
2162149-24-6 |
詳細(xì)
|
| Asciminib hydrochloride |
阿思尼布鹽酸鹽 |
2119669-71-3 |
詳細(xì)
|
| Thiamine disulfide |
二硫化硫胺 |
67-16-3 |
詳細(xì)
|
| BIIB091 |
1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 1-(1,1-DIMETHYLETHYL)-N-[(5R)-2,3,4,5-TETRAHYDRO-8-[2-[(1-METHYL-1H-PYRAZOL-4-YL)AMINO]-4-PYRIMIDINYL]-2-(3-OXETANYL)-1H-2-BENZ |
2247614-80-6 |
詳細(xì)
|
| Elsubrutinib |
ELSUBRUTINIB |
1643570-24-4 |
詳細(xì)
|
| CPL304110 |
化合物 CPL304110 |
1627826-19-0 |
詳細(xì)
|
| EDP-305 |
醋酸妊娠雙烯醇酮酯雜質(zhì)15 |
1933507-63-1 |
詳細(xì)
|
| Atuveciclib Racemate |
RINTODESTRANT |
2088518-51-6 |
詳細(xì)
|
| KSQ-4279 |
KSQ-4279 |
2446480-97-1 |
詳細(xì)
|
| RMC-5552 |
RMC-5552 |
2382768-62-7 |
詳細(xì)
|
| Zunsemetinib |
ZUNSEMETINIB |
1640282-42-3 |
詳細(xì)
|
| Zotizalkib |
TPX-0131 |
2648641-36-3 |
詳細(xì)
|
| LY3372689 |
LY3372689 |
2241514-56-5 |
詳細(xì)
|
| Deferoxamine |
去鐵胺 |
70-51-9 |
詳細(xì)
|
| Aniracetam |
化合物 BRADANICLINE |
639489-84-2 |
詳細(xì)
|
| MAX-40279 |
化合物 MAX-40279 |
2070931-57-4 |
詳細(xì)
|
| ORIC-101 |
ORIC-101 |
2222344-98-9 |
詳細(xì)
|
| Cemdisiran |
ALN-CC5 |
1639264-46-2 |
詳細(xì)
|
| LXE408 |
LXE 408 |
1799330-15-6 |
詳細(xì)
|
| Rezivertinib |
REZIVERTINIB |
1835667-12-3 |
詳細(xì)
|
| Iruplinalkib |
伊魯阿克 |
1854943-32-0 |
詳細(xì)
|
| limertinib |
ASK120067 |
1934259-00-3 |
詳細(xì)
|
| Vemircopan |
VEMIRCOPAN |
2086178-00-7 |
詳細(xì)
|
| Pactimibe |
7-[(2,2-二甲基-1-氧代丙基)氨基]-2,3-二氫-4,6-二甲基-1-辛基-1H-吲哚-5-乙酸 |
189198-30-9 |
詳細(xì)
|
| Fosgonimeton |
肝細(xì)胞生長因子受體激動劑多肽 |
2093305-05-4 |
詳細(xì)
|
| Osunprotafib |
ABBV-CLS-484 |
2489404-97-7 |
詳細(xì)
|
| Zaloglanstat |
ZALOGLANSTAT |
1513852-12-4 |
詳細(xì)
|
| ISIS 104838 |
化合物 ISIS 104838 |
250755-32-9 |
詳細(xì)
|
| AMXI-5001 |
AMXI-5001 |
2170491-77-5 |
詳細(xì)
|
| Bezuclastinib |
CGT-9486 |
1616385-51-3 |
詳細(xì)
|
| CC-90005 |
CC-90005 |
1799574-70-1 |
詳細(xì)
|
| Branaplam hydrochloride |
布拉撲蘭鹽酸鹽 |
1562338-39-9 |
詳細(xì)
|
| Dovramilast |
化合物 DOVRAMILAST |
340019-69-4 |
詳細(xì)
|